Trening

Rehabilitering etter hjertesykdom

Koronarsykdom

Pasientinformasjon

Hjerte/kar

Kliniske kapitler

Håndboken

Norsk Elektronisk Legehåndbok

Hvem har nytte av hjerterehabilitering?

Hva består rehabiliteringsprogrammet i?

Ulike faser i et rehabiliteringsprogram

Noen detaljer

En bedre prognose

Vil du vite mer?

Hjerteinfarkt

--&gt; http://dx.doi.org/10.1093/eurheartj/ehad191

Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J 2023. doi:10.1093/eurheartj/ehad191 

--&gt; http://dx.doi.org/10.1093/eurheartj/ehy462

Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019; 40: 237-69. doi:10.1093/eurheartj/ehy462 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=33191769[uid]

Reynolds HR, Maehara A, Kwong RY, et al. Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of MINOCA in women. Circulation 2020. PMID: 33191769 

--&gt; https://www.fhi.no/hn/helseregistre-og-registre/hjertekar/forekomst-av-hjerte--og-karsykdommer-i-2021/

Folkehelseinstituttet. Forekomst av hjerte- og karsykdom i 2021. Hjerte- og karregisteret. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=27617629[uid]

Albrektsen G, Heuch I, Løchen M-L, et al. Lifelong gender gap in risk of incident myocardial infarction. The Tromsø Study. JAMA Intern Med 2016; 176: 1673-9. pmid:27617629 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=34406326[uid]

van Rosendael AR, van den Hoogen IJ, Gianni U, et al. Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition. JAMA Cardiol 2021. pmid:34406326 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=33568434[uid]

Singh T, Chapman AR, Dweck MR, et al. MINOCA: a heterogenous group of conditions associated with myocardial damage. Heart 2021; 107: 1458-64. pmid:33568434 

Journal of the American Medical Association

Kodama S, Saito K, Tanaka S, Maki M, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women. A meta-analysis. JAMA 2009; 301: 2024 - 35. 

Anderssen SA, Hjermann I. Fysisk aktivitet - en sentral faktor i forebyggingen av hjerte- og karsykdom. Tidsskr Nor Lægeforen 2000; 120: 3168-72. 

Murabito JM, Pencina MJ, Nam BH, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA. 2005; 294: 3117-23. 

Gotto AM jr., LaRosa JC, Hunninghake D, Grundy SM, Wilson PW, Clarkson TB et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung and Blood Institute. Circulation 1990; 81: 1721-33. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=35583863[uid]

Liu C, Dhindsa D, Almuwaqqat Z, et al. Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations. JAMA Cardiol 2022. pmid:35583863 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=Circulation[ta]+AND+147[vol]+AND+23[page]

Raitakari O, Kartiosuo N, Pahkala K, et al. Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood. Circulation. 2023;147(1):23-31. 

Kessous R, Shoham-Vardi I, Pariente G, et al. Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart 2014. doi:10.1136/heartjnl-2014-306571 

Fowler G. Tobacco and cardiovascular disease: achieving smoking cessation . I: Yusuf S, red. Evidence based cardiology. London: BMJ Books, 1998: 179-90. 

Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=36841256[uid]

Dean YE, Shebl MA, Rouzan SS, et al. Association between insomnia and the incidence of myocardial infarction: A systematic review and meta-analysis. Clin Cardiol 2023. pmid:36841256 

Lakka H-M, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronar events in men. Eur Heart J 2002; 23: 706-13. 

Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: A meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007; 167: 1720-8. 

Hsia J, Larson JC, Ockene JK, et al. Resting heart rate as a low tech predictor of coroanary events in women: prospective cohort study. BMJ 2009; 338: b219. 

Schjerning Olsen A, Fosbøl L, Lindhardsen J, et al. Long-term cardiovascular risk of NSAID use according to time passed after first-time myocardial infarction. A nationwide cohort study. Circulation 2012. doi:10.1161/​CIRCULATIONAHA.112.112607 

Lindhardsen J, Ahlehoff O, Gislason GH, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011; 70: 929-934. 

Mehta NN, Yu Y, Pinnelas R, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011; 124: 775. 

--&gt; http://dx.doi.org/10.1001/jamanetworkopen.2022.3849

Biddinger KJ, Emdin CA, Haas ME, et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Netw Open 2022; 5: e223849. doi:10.1001/jamanetworkopen.2022.3849 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=29365305[uid]

Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 2018; 378: 345-53. pmid:29365305 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=34459211[uid]

Frøbert O, Götberg M, Erlinge D, et al. Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Circulation 2021. pmid:34459211 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=29459463[uid]

Lichtman JH, Leifheit EC, Safdar B, et al. Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: Evidence from the VIRGO study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients. Circulation 2018; 137: 781. pmid:29459463 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=37080764[uid]

Kumar A, Sanghera A. Sanghera B, et al. Chest pain symptoms during myocardial infarction in patients with and without diabetes: a systematic review and meta-analysis. Heart 2023. pmid:37080764 

Ammann P, Pfisterer M, Fehr T, Rickli H. Raised cardiac troponins. BMJ 2004; 328: 1028-9. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=36707129[uid]

Farhat-Sabet A, Snith A, Atwood JE, Pickett C. Localising culprit artery in inferior STEMI . Open Heart 2023; 10: e002093. pmid:36707129 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=26542793[uid]

Bischof JE, Worrall C, Thompson P, et al. ST depression in lead aVL differentiates inferior ST-elevation myocardial infarction from pericarditis. Am J Emerg Med 2016. PMID: 26542793 

--&gt; http://dx.doi.org/10.1001/jamainternmed.2022.0519

Zhang C, Li T, Chen X. Acute Myocardial Infarction or Not? JAMA Intern Med. Published online April 18, 2022. doi:10.1001/jamainternmed.2022.0519 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=34038535[uid]

Jortveit J, Pripp AH, Halvorsen S. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway. Eur Heart J 2021. pmid:34038535 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=36877502[uid]

Sanchis J, Bueno H, Miñana G, et al. Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non–ST-Segment Elevation Acute Myocardial Infarction A Randomized Clinical Trial. JAMA Intern Med 2023. pmid:36877502 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=30355567[uid]

Siemieniuk RAC, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ 2018; 363: k4169. pmid:30355567 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=29599378[uid]

Sepehrvand N, James SK, Stub D, et al. Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials. Heart 2018. pmid:29599378 

--&gt; http://dx.doi.org/10.1002/14651858.CD007160.pub4

Cabello JB, Burls A, Emparanza JI, Bayliss SE, Quinn T. Oxygen therapy for acute myocardial infarction. Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No.: CD007160. DOI: 10.1002/14651858.CD007160.pub4. 

Grønvold T, Evang JA, Stensæth KH. En 51 år gammel kvinne med akutte brystsmerter. Tidsskr Nor Legeforen 2008; 128: 2836-8. 

Hole T, Juvkam PC, Lied A. Primærlegebasert prehospital trombolytisk behandling ved akutt hjarteinfarkt. Tidsskr Nor Lægeforen 2005; 125: 1486-8. 

Choo EH, Chang K, Ahn Y, et al. Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention. Heart 2013. doi:10.1136/heartjnl-2013-305137 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=37130746[uid]

Ishak D, Aktaa S, Lindhagen L, et al. Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes. Heart 2023. pmid:37130746 

Reikvam Å, Madsen S. Hvordan skal ACE-hemmere brukes ved hjerteinfarkt? Tidsskr Nor Lægeforen 2000; 120: 3413-7. 

Pitt B, White H, Nicolau J, et al. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 2005; 46: 425-31. 

Ezekowitz JA, McAlister FA. Aldosteron blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J 2009; 30: 469-77. 

Bøtker HE, Kharbanda R, Schmidt MR, et al. Remote ischemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010; 375: 727-34. 

--&gt; http://dx.doi.org/10.1136/heartjnl-2015-308980

Pryds K, Terkelsen CJ, Sloth AD, et al. Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction. Heart 2016. doi:10.1136/heartjnl-2015-308980 

--&gt; http://dx.doi.org/10.1016/S0140-6736(19)32039-2

Hausenloy DJ, Kharbanda RK, Møller UK, et al. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. Lancet 2019. doi:10.1016/S0140-6736(19)32039-2 

--&gt; http://dx.doi.org/10.1136/openhrt-2019-001169

Fernández-Bergés D, Degano IR, Fernandez RG, et al. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction. Open Heart 2020. doi:10.1136/openhrt-2019-001169 

Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006; 355: 2395-2407. 

--&gt; http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046251

O'Donoghue ML, Murphy SA, Sabatine MS. The safety and efficacy of aspirin discontinuation on a background of a P2Y12 inhibitor in patients after percutaneous coronary intervention: A systematic review and meta-analysis. Circulation 2020 Jun 19; doi: 10.1161/CIRCULATIONAHA.120.046251 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=31253632[uid]

Yin SH, Xu P, Wang B, et al. Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis. BMJ 2019; 365: l2222. pmid:31253632 

Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e4-e17. doi:10.1161/CIR.0000000000001039Circulation. 2022;145:e4–e17 

Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481-88. 

Rizos EC, Ntzani E, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. JAMA 2012; 308: 1024-33. 

Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic . Ann Intern Med 2014; 160: 398-406. doi:10.7326/M13-1788 

Sesso HD, Christen WG, Bubes V, et al. Multivitamins in the Prevention of Cardiovascular Disease in Men: The Physicians` Health Study II Randomized Controlled Trial. JAMA 2012 Nov 7; 308(17): 1751-60. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=29852980[uid]

Jenkins DJA, Spence JD, Giovannucci EL, et al. Supplemental Vitamins and Minerals for CVD Prevention and Treatment. J Am Coll Cardiol. 2018 Jun 5;71(22):2570-2584. PMID: 29852980. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=37043192[uid]

Rhee T-M, Bae J-W, Park KW, et al. Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes A Post Hoc Analysis of the HOST-EXAM Trial. JAMA Cardiol 2023. pmid:37043192 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=35368058[uid]

Räber L, Ueki Y, Otsuka T, et al. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction The PACMAN-AMI Randomized Clinical Trial. JAMA 2022; 327: 1771-81. pmid:35368058 

--&gt; http://dx.doi.org/10.1136/bmj.o1444

BMJ News. NICE endorses new drug to prevent myocardial infarctions and strokes. BMJ 2022; 377: o1444. doi:10.1136/bmj.o1444 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=35483753[uid]

Gaba P, Bhatt DL, Steg PG, et al. Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. J Am Coll Cardiol 2022; 79: 1660-71. pmid:35483753 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=32542362[uid]

Kim J, Kang D, Park H, et al. Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study. Eur Heart J 2020; 41: 3521. pmid:32542362 

--&gt; http://www3.interscience.wiley.com/cochrane/mainSearch?mode=startsearch&amp;Query1=Exercise‐based cardiac rehabilitation for coronary heart disease&amp;zones1=article-title&amp;opt1=AND&amp;Query2=&amp;zones2=article-title&amp;opt2=AND&amp;Query3=&amp;zones3=author&amp;opt3=AND&amp;Query4=&amp;zones4=abstract&amp;opt4=AND&amp;Query5=&amp;zones5=keywords&amp;products=all&amp;unitstatus=none&amp;FromYear=&amp;ToYear=&amp;x=22&amp;y=13

Dibben G, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler A-D, Taylor RS. Exercise‐based cardiac rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews 2021, Issue 11. Art. No.: CD001800. DOI: 10.1002/14651858.CD001800.pub4. Accessed 22 November 2023. 

Dalal HM, Zawada A, Jolly K, Moxham T, Taylor RS. Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis. BMJ 2010; 340: b5631. 

Frobert O, Gotberg M, Erlinge D, et al. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Circulation. 2021. PMID: 34459211 

--&gt; http://dx.doi.org/10.1056/NEJMoa1707914

Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017. doi:10.1056/NEJMoa1707914 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=31733140[uid]

Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med 2019. PMID: 31733140 

Cucherat M, Bonnefoy E, Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Oxford: The Cochrane Library, issue 2, 2002. 

--&gt; http://dx.doi.org/10.1093/eurheartj/ehx393

Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119-77. doi:10.1093/eurheartj/ehx393 

Solomon SD, Zelenkofske S, McMurray JJ, et al, for the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352: 2581-8. 

Lichtman JH, Bigger JT, Blumenthal JA et al. Depression and coronary heart disease. Circulation 2008; 118: . 

--&gt; https://www.fhi.no/nyheter/2019/dodsfall-etter-hjerteinfarkt-og-hjerneslag-er-dramatisk-redusert-siste-ti-a/

Folkehelseinstituttet. Dødsfall etter hjerteinfarkt og hjerneslag er dramatisk redusert. Dødsårsaksregisteret. Publisert 04.12.2019 

--&gt; https://www.fhi.no/contentassets/4489efb7f1f8462293a62b46e0f2d924/30-dagers-overlevelse-og-reinnleggelse-etter-sykehusinnleggelse-2019-hovedrapport.pdf

Folkehelseinstituttet. Kvalitet i helsetjenesten. 30 dagers overlevelse og reinnleggelse etter sykehusinnleggelse. Resultater for 2019. FHI 2020. 